Market Place
Market Place
Post Enquiry
Top drugs and pharmaceutical companies of 2019 by revenues
Acquisitions and spin-offs dominated headlines in 2019 and the tone was set very early with Bristol-
Seven of your facilities are out of compliance, FDA tells Wockhardt; Mylan’s EpiPen sales crash
In Phispers this week, there is news on how alternatives to Mylan’s EpiPen have eaten into it
Record fine levied on Pfizer for hiking drug price; US Senate clears biggest drug approval reform
This week, the US Senate cleared the 21st Century Cures bill, touted as the most significant reform
The Next Generic Attack: Brilinta® (Ticagrelor), Xarelto® (Rivaroxaban), Tradjenta® (Linagliptin) and…
With almost 30,000 Drug Master Files (DMFs) submitted to the
FDA, reviewing the filings of only the
Dr. Reddy’s expansion plans for API production
Unrelated to the inspection of
the USFDA at the Dr. Reddys Srikakulam facility, Dr. Reddys sought pe
